![](/img/cover-not-exists.png)
Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study
J. Thaler, G. Gastl, T. Fluckinger, D. Niederwieser, H. Huber, H. Seewann, H. Sill, A. Lang, M. Falk, C. Duba, G. Utermann, T. Kühr, W. Aulitzky, C. Huber, Austrian Biological Response Modifier (BRM)Volume:
72
Language:
english
Pages:
7
DOI:
10.1007/s002770050185
Date:
June, 1996
File:
PDF, 228 KB
english, 1996